US EditionTrump's FDA Nominee Advances After Addressing Vaccine Question in Confirmation Hearing
- Makary's agenda includes focusing on vaccine safety and transparency in health agencies, as stated during his confirmation hearing.
- Senator Bernie Sanders expressed opposition, citing concerns over public trust in the FDA and affordability of medical treatments.
- Senator Bill Cassidy emphasized the need for leadership committed to transparency in addressing public health issues.
6 Articles
6 Articles
Senate Confirms Makary as Head of FDA
Dr. Marty Makary, President Donald Trump’s nominee to lead the Food and Drug Administration, was confirmed by the Senate in a 56–44 vote on March 25. Makary is aligned with HHS Secretary Robert F. Kennedy’s Make America Healthy Again platform and shares his focus on vaccine safety, addressing the nation’s chronic disease epidemic, removing chemicals and toxins from food, and bringing transparency to government health agencies. “Childhood obesity…
Senate Confirms Pro-Life Doctor Marty Makary to Head FDA
The U.S. Senate confirmed Dr. Marty Makary as the new Commissioner of Food and Drugs, placing the Johns Hopkins surgeon and health policy expert at the helm of the FDA. Makary garnered enough support from both Republicans and several Democrats to secure confirmation. Trump’s nominee to head the FDA, pro-life Dr. Marty Makary,comes at a key time when pro-life groups are pushing to stop or restrict the dangerous mifepristone abortion pill that has…
Senate confirms Makary for FDA commissioner
The Senate late Tuesday voted 56-44 to confirm Martin Makary to lead the Food and Drug Administration. Makary, a former Johns Hopkins University surgeon and author, has been widely seen as a more middle-of-the-road pick compared to Trump’s other choices to lead the Department of Health and Human Services’ subagencies. He will take over leadership of the agency as the FDA has been targeted by sweeping cuts by Elon Musk’s so-called Department of…
Coverage Details
Bias Distribution
- 75% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
